OCUPHIRE PHARMA INC. - COMMON STOCK
1,2900
27-сентября-24 14:59:54
15 мин. задержка
Акции
-0,0100
-0,77%
Сегодняшний диапазон
1,2502 - 1,3050
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Ocuphire Pharma Announces Financial Results for First Quarter 2023 and Provides Corporate Update
15 май 2023 07:00:01 Источник Nasdaq GlobeNewswire
-
Ocuphire Announces APX3330 and Nyxol® Data Presentations at ASCRS 2023 and Eyecelerator
02 май 2023 07:30:00 Источник Nasdaq GlobeNewswire
-
Ocuphire Provides Corporate Update and Reiterates Previous Guidance on Clinical Programs
25 апр 2023 07:00:01 Источник Nasdaq GlobeNewswire
-
Ocuphire Appoints Rick Rodgers as Interim Chief Executive Officer
21 апр 2023 07:00:00 Источник Nasdaq GlobeNewswire
-
30 мар 2023 07:00:00 Источник Nasdaq GlobeNewswire
-
Ocuphire Announces APX3330 and Nyxol® Data Presentations at ARVO 2023 Annual Meeting
23 мар 2023 07:00:01 Источник Nasdaq GlobeNewswire
-
Ocuphire Announces APX3330 Phase 2 Data Presentations at Retina Meetings
16 фев 2023 07:30:01 Источник Nasdaq GlobeNewswire
-
13 фев 2023 07:00:00 Источник Nasdaq GlobeNewswire
-
25 янв 2023 15:01:00 Источник Nasdaq GlobeNewswire
-
09 янв 2023 06:00:01 Источник Nasdaq GlobeNewswire
-
06 дек 2022 05:00:00 Источник Nasdaq GlobeNewswire
-
Ocuphire to Present at Five Upcoming Investor/Industry Conferences
21 ноя 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
07 ноя 2022 15:05:00 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Financial Results for Third Quarter 2022 and Provides Corporate Update
04 ноя 2022 15:30:00 Источник Nasdaq GlobeNewswire
-
02 ноя 2022 07:09:57 Источник Nasdaq GlobeNewswire
-
24 окт 2022 07:56:52 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present at the MicroCap Rodeo Windy City Roundup 2022 Conference
07 окт 2022 06:00:00 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma Hosting Key Opinion Leader Event on Oral APX3330 for Diabetic Eye Disease
06 окт 2022 08:27:49 Источник Nasdaq GlobeNewswire
-
Ocuphire Expands Medical Advisory Board with Seven New KOLs and Strengthens Leadership Team
29 сен 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
15 сен 2022 06:00:01 Источник Nasdaq GlobeNewswire